Both in Pharmaceuticals
Spyre Therapeutics vs TG Therapeutics
Over the past year SYRE returned +317.5% and TGTX returned +80.3%; their daily moves had a correlation of 0.33.
SYRE +317.5% TGTX +80.3%Growth of $1, one year, split-adjusted
| Metric | SYRE | TGTX |
|---|---|---|
| Price | $99.27 | $60.75 |
| Market cap | $9.28B | $9.30B |
| Today | +3.94% | +1.33% |
| 1 month | +7.1% | +12.7% |
| 6 months | +39.8% | +68.3% |
| Year to date | +203.0% | +103.8% |
| 1 year | +305.8% | +74.7% |
| Revenue growth (YoY) | — | +70.3% |
| Gross margin | — | 82.9% |
| Net margin | — | 3.2% |
| P/E (TTM) | — | 21.1× |
| Price / sales | — | 11.6× |
| Net cash | $1.15B | -$193.1M |
| Dividend yield | — | — |
| Volatility (60d) | 59.2% | 36.8% |
| Short % of float | 15.6% | 20.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).